Epstein-barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients

Am J Transplant. 2009 Dec:9 Suppl 4:S87-96. doi: 10.1111/j.1600-6143.2009.02898.x.

Authors

U Allen¹, J Preiksaitis; AST Infectious Diseases Community of Practice

Affiliation

¹ Division of Infectious Diseases, Hospital for Sick Children, University of Toronto, Ontario, Canada. upton.allen@sickkids.ca

PMID: 20070701
DOI: 10.1111/j.1600-6143.2009.02898.x

No abstract available

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antiviral Agents / therapeutic use
Epstein-Barr Virus Infections / epidemiology
Epstein-Barr Virus Infections / etiology*
Epstein-Barr Virus Infections / therapy
Humans
Lymphoproliferative Disorders / epidemiology
Lymphoproliferative Disorders / etiology*
Lymphoproliferative Disorders / therapy
Monitoring, Physiologic
Organ Transplantation / adverse effects*
Prognosis
Risk Factors
Viral Load

Substances

Antibodies, Monoclonal
Antiviral Agents